Accepted Manuscript Mechanistic Link between Diesel Exhaust Particles and Respiratory Reflexes Ryan K. Robinson, BSc, Mark A. Birrell, PhD, John J. Adcock, PhD, Michael A. Wortley, PhD, Eric D. Dubuis, PhD, Shu Chen, PhD, Catriona M. McGilvery, PhD, Sheng Hu, PhD, Milo SP. Shaffer, PhD, Sara J. Bonvini, PhD, Sarah A. Maher, PhD, Ian S. Mudway, PhD, Alexandra E. Porter, PhD, Chris Carlsten, MD, Teresa D. Tetley, PhD, Maria G. Belvisi, PhD
PII:
S0091-6749(17)30796-0
DOI:
10.1016/j.jaci.2017.04.038
Reference:
YMAI 12819
To appear in:
Journal of Allergy and Clinical Immunology
Received Date: 22 November 2016 Revised Date:
14 April 2017
Accepted Date: 26 April 2017
Please cite this article as: Robinson RK, Birrell MA, Adcock JJ, Wortley MA, Dubuis ED, Chen S, McGilvery CM, Hu S, Shaffer MS, Bonvini SJ, Maher SA, Mudway IS, Porter AE, Carlsten C, Tetley TD, Belvisi MG, Mechanistic Link between Diesel Exhaust Particles and Respiratory Reflexes, Journal of Allergy and Clinical Immunology (2017), doi: 10.1016/j.jaci.2017.04.038. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
DEP
CH-223191
EP
Airway C-fibre
AC C
AhR
PAH
Calcium Jan 130
TRPA1
TE D
M AN U
ROS
SC
RI PT
ACCEPTED MANUSCRIPT Airway cells
Mitochondrion
ROS mitoTEMPO
NAC
Action potential [Ca2+]i Symptoms
DEP: Diesel exhaust particles; TRPA1: transient receptor potential Ankyrin-1; PAH’s: Polycyclic aromatic hydrocarbons; ROS: Reactive oxygen species.
ACCEPTED MANUSCRIPT
Mechanistic Link between Diesel Exhaust Particles and Respiratory Reflexes Ryan K Robinson BSc1, 2, Mark A Birrell PhD1, 2, John J Adcock PhD1, Michael A Wortley PhD1, Eric D Dubuis PhD1, Shu Chen PhD3, Catriona M McGilvery PhD3, Sheng Hu PhD4, Milo SP Shaffer PhD3,4, Sara J Bonvini PhD1, Sarah A Maher PhD1, Ian S Mudway PhD5, 6,
RI PT
Alexandra E Porter PhD3,6, Chris Carlsten MD7, Teresa D Tetley PhD6,8*, Maria G Belvisi PhD 1,2*.
Affiliations:
Respiratory Pharmacology Group, Airway Disease, National Heart & Lung Institute, Imperial College
London, exhibition Road, London SW7 2AZ, UK.
SC
1
MRC & Asthma UK Centre in Allergic Mechanisms of Asthma
3
Department of Materials and London Centre for Nanotechnology, Imperial College London,
Exhibition Road, London SW7 2AZ, UK. 4
M AN U
2
Department of Chemistry and London Centre for Nanotechnology, Imperial College London, SW7
2AZ, UK.
MRC-PHE Centre for Environment and Health, King’s College London, London, SE14 5EQ, UK
6
NIHR Health Protection Research Unit in Health Impact of Environmental Hazards.
7
University of British Columbia, Vancouver, BC, Canada
8
Lung Cell Biology, Airways Disease, National Heart & Lung Institute, Imperial College London,
TE D
5
AC C
*Correspondence to:
EP
Dovehouse Street, London, SW3 6LY, UK.
Professor Maria G. Belvisi; Address: Respiratory Pharmacology Group, Airway Disease, National Heart & Lung Institute, Imperial College London, exhibition Road, London SW7 2AZ, UK; Phone: +44 20 7594 7828; e-mail:
[email protected]; Professor Teresa Tetley: Address: Lung Cell Biology, Airways Disease, National Heart & Lung Institute, Imperial College London, Dovehouse Street, London, SW3 6LY, UK.; Phone: +44 20 7594 2984; e-mail:
[email protected]
1
ACCEPTED MANUSCRIPT Author Contributions: Conception and design: MAB, TDT, RKR, MAB; analysis and interpretation: MGB, MAB, RKR, TDT; CC data generation, analysis and interpretation: MGB, RKR, MAB, SJB, JJA, SAM, IAS, MAW, ED, AEP, MSPS, CMcG, SC; SH; writing the paper: MGB, RKR, TDT. Funding: RKR was funded by a BBSRC Doctoral Training Programme; SAM and ED were funded by a
RI PT
Medical Research Council (MRC, UK) MICA award (MR/K020293/1). SJB was supported by a National Heart & Lung Institute (NHLI) studentship. MAW was funded by the North West Lung Centre Charity. The human vagus experiments in this study were undertaken with the support of the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation
AC C
EP
TE D
M AN U
SC
Trust.
2
ACCEPTED MANUSCRIPT ABSTRACT Background: Diesel exhaust particles (DEP) are a major component of particulate matter in Europe’s largest cities and epidemiological evidence links exposure with respiratory symptoms and asthma
RI PT
exacerbations. Respiratory reflexes are responsible for symptoms and are regulated by vagal afferent nerves which innervate the airway. It is not known how DEP exposure activates airway afferents to elicit symptoms such as cough and bronchospasm.
SC
Objective: To identify the mechanisms involved in the activation of airway sensory afferents by DEPs. Methods: In this study we utilize in vitro and in vivo electrophysiological techniques including a
M AN U
unique model which assess depolarization (a marker of sensory nerve activation) of human vagus. Results: We demonstrate a direct interaction between DEP and airway C-fiber afferents. In anaesthetized guinea pigs, intratracheal administration of DEP activated airway C-fibers. The organic extract (DEP-OE), and not the cleaned particles, evoked depolarization of guinea-pig and human vagus
TE D
and this was inhibited by a TRPA1 antagonist and the antioxidant N-acetyl cysteine (NAC). Polycyclic aromatic hydrocarbons (PAHs), major constituents of DEP, were implicated in this process via activation of the aryl hydrocarbon receptor (AhR) and subsequent mitochondrial ROS production,
EP
which is known to activate TRPA1 on nociceptive C-fibers.
AC C
Conclusions: This study provides the first mechanistic insights into how exposure to urban air pollution leads to activation of guinea-pig and human sensory nerves which are responsible for respiratory symptoms. Mechanistic information will enable the development of appropriate therapeutic interventions and mitigation strategies for those susceptible individuals who are most at risk.
3
ACCEPTED MANUSCRIPT Key messages: •
Exposure to diesel exhaust particles (DEP) is associated with respiratory symptoms but the mechanisms involved are unknown. Here we demonstrate a direct interaction between DEP and the activation of airway C-fiber afferents.
RI PT
•
Polycyclic aromatic hydrocarbons (PAHs) were implicated in this process via
activation of the aryl hydrocarbon receptor (AhR) and subsequent mitochondrial ROS
These findings explain how exposure to DEP leads to the activation of human sensory nerves
M AN U
•
SC
production.
which are responsible for respiratory symptoms and could explain how air pollution can cause disease exacerbations in susceptible groups such as those with asthma.
TE D
Capsule Summary: These findings provide the first mechanistic insights into how exposure to urban air pollution leads to the activation of human sensory nerves which are responsible for respiratory
EP
symptoms.
vagus.
AC C
Keywords: Pollution, oxidative stress, transient receptor potential (TRP) ion channels, sensory nerves,
Abbreviations: Transient receptor potential (TRP), particulate matter (PM), diesel exhaust particles (DEP), aryl hydrocarbon receptor (AhR), polycyclic aromatic hydrocarbons (PAH’s), reactive oxygen species (ROS)
4
ACCEPTED MANUSCRIPT INTRODUCTION Air pollution is a major global health concern especially in industrialized countries1. In urban environments exposure to traffic-derived particulate matter (PM) has been a major focus, especially
RI PT
with regard to primary tail pipe emissions from diesel vehicles. Smaller fractions of PM, because its size and low density are able to remain airborne, disperse widely in the environment and penetrate deep into the lungs when inhaled to distribute throughout the respiratory tract. There is currently no
SC
safe lower limit of exposure to PM. Diesel exhaust particles (DEP) represent a significant proportion of urban PM2,3 especially within Europe due to the high proportion of diesel vehicles4 and ongoing
M AN U
problems with emission compliance5. Epidemiological studies have found strong associations between exposure to DEP, or air pollution markers indicative of diesel exhaust (black and elemental carbon), and respiratory symptoms including cough, wheeze and shortness of breath6,7, hospital admissions8 and mortality9. Clinical studies utilizing diesel exposure have documented increases in total symptom
TE D
scores10,11 and increased airway resistance12.
However, information regarding the molecular
mechanism linking DEP exposure and respiratory symptoms is lacking.
EP
Respiratory reflexes are responsible for symptoms and are regulated by vagal afferent nerves which
AC C
innervate the airway13-15. There are several different sensory nerve subtypes present in the lung, some are more mechanically sensitive and others more chemosensitive; namely C-fibers and Aδfibers, respectively. Transient receptor potential (TRP) channels present on vagal nerve termini situated in and under the airway epithelium can be activated by a wide variety of stimuli to elicit reflexes leading to respiratory symptoms. These include mechanical and inflammatory stimuli, environmental irritants and changes in osmolarity, pH or temperature16,
17
. Upon activation TRP
channels allow the influx of calcium into the cell leading to subsequent membrane depolarization and 5
ACCEPTED MANUSCRIPT ultimately the generation of an action potential that propagates along the vagus nerve18. Interestingly, one publication has demonstrated DEP-induced activation of TRPV4 expressed in an epithelial cell line and another showed activation of TRPA1 on murine dorsal root ganglion cells19, 20.
RI PT
Our hypothesis was that DEP are able to initiate respiratory symptoms via direct activation of lung specific afferent sensory nerves. The scope of this study was to determine whether DEP can directly activate airway sensory nerves using a range of human and animal in vitro models and in vivo
M AN U
responsible and the signaling mechanisms involved.
SC
electrophysiological studies in an animal model. We also evaluated which component of DEP was
METHODS - Detailed methods are provided in the online supplement.
Animals
TE D
Male Dunkin-Hartley guinea-pigs and C57BL/6 mice were used. All experiments were performed in accordance with the U.K. Home Office guidelines for animal welfare based on the Animals (Scientific
AC C
EP
Procedures) Act of 1986 and the ARRIVE guidelines21.
Human Tissue and Ethics
Human lung and trachea surplus to transplant requirements (N=3, 56-73 years old, 1 male/2 female, 1 smoker/2 non-smokers), with the vagus nerve still attached, were used to obtain translational data to complement data generated in guinea pig tissue. Tissue was provided by the International Institute for the Advancement of Medicine (IIAM, Edison, New Jersey, USA). In all cases the tissue was
6
ACCEPTED MANUSCRIPT approved for use in scientific research and ethical approval was obtained from the Royal Brompton & Harefield Trust.
RI PT
Compounds and Materials Diesel exhaust particles from a forklift truck (DEP - SRM-2975) and its commercial organic extract (DEP-OE - SRM-1975) were purchased from the National Institute of Standards and Technology (NIST,
SC
Gaithersburg, USA). Generator DEP, obtained from the Air Pollution Exposure Laboratory (APEL), was obtained which has been designed for the controlled inhalation of human subjects to aged and
M AN U
diluted diesel exhaust to mimic “real-world” occupational and environmental conditions22. Drugs (listed in the supplementary methods) were made up in stock solutions using DMSO, with the final
Particle Suspensions
TE D
concentration of DMSO kept at 0.1% for experiments.
Particle suspension solutions were freshly prepared daily. Suspensions of DEP or cleaned particulate carbon core (par-DEP) were prepared in a modified Krebs-Henseliet solution by sonication before
AC C
similar manner.
EP
dilution to working concentrations. For in vivo experiments, suspensions were prepared in PBS in a
Physicochemical characterization of DEP Cryo preparation was performed done using an automatic plunge freezer. Nanoparticles, dispersed in (1µg/ml in Krebs), were dropped onto a grid and frozen by rapidly plunging into liquid ethane. These were transferred in their frozen state into a cryo-rod and then into the electron microscope. For chemical analysis, DEP samples were dispersed by sonication in ethanol and then pipetted onto a grid 7
ACCEPTED MANUSCRIPT at room temperature. TEM and Energy Dispersive X-ray Spectroscopy (EDX) analysis was performed. The organic/inorganic ratio composition of SRM 2975 was assessed using thermogravemetric analysis (TGA). Dynamic light scattering (DLS) measurements were also carried out as described in
DEP) using Soxhlet extraction.
SC
In vivo recording of action potential firing in single-fiber afferents.
RI PT
supplementary text. DEP was separated into the organic extract (org-DEP) and cleaned particles (par-
Guinea-pigs were anaesthetized with urethane (1.5 g/kg) intraperitoneally. The trachea was
M AN U
cannulated and the animal artificially ventilated. The right jugular vein and carotid artery were cannulated for respectively injecting drugs and measuring systemic arterial blood pressure. Animals were paralysed with vecuronium bromide, initially administered at a dose of 0.10 mg/kg, i.v., followed every 20 min with 0.05 mg/kg, i.v. to maintain paralysis. The depth of anaesthesia was frequently
TE D
assessed by monitoring the response of heart rate and blood pressure to noxious stimuli (as described below). Both cervical vagus nerves were located, via a cervical incision, and dissected free; both vagus nerves were cut at the central end. The left vagus nerve was used for sensory nerve fiber recording as
EP
previously described23 (diagram of experimental set up can be found in a recent review article16).
AC C
Following identification of a suitable single nerve fiber, control responses were obtained to capsaicin (100µM in saline, aerosolized for 15s), acrolein (10mM in saline, aerosolized for 60 s) and citric acid (300mM, aerosolized for 60s). The nerve under investigation was then challenged with either vehicle (PBS, 200µL) or DEP (10 µg/ml in PBS, 200µL, intratracheal dose) and subsequent action potentials recorded. For antagonist studies, control responses were obtained to capsaicin (100µM in saline, aerosolized for 15s), acrolein (10mM in saline, aerosolized for 60s) and DEP-OE (1 µg/ml in saline, aerosolized for 60s) prior to the introduction of Janssen 130 (30mg/kg, 1% methyl cellulose in saline) 8
ACCEPTED MANUSCRIPT into the animal via intravenous route 60 minutes before challenging again with capsaicin, acrolein and DEP-OE. At the end of the experiment, the conduction velocity of the single nerve fiber was measured to determine whether it was a slow conducting non-myelinated C-fiber or a fast conducting
RI PT
myelinated Aδ-fiber. Using the same experimental set up with the vagus nerves left intact and in the
of airflow obstruction which was expressed as mean ± SEM.
In vitro measurement of isolated vagus nerve depolarization
SC
absence of neuromuscular blockade we assessed tracheal pressure (PT ∆ increase cmH2O) as a marker
M AN U
Guinea pigs and mice were sacrificed by injection of sodium pentobarbitone (200 mg/kg i.p.) and the vagus nerves were dissected and depolarization assessed as a measure of sensory nerve activation as described in previous publications24-26. Human vagus was obtained from IIAM as previously described
Data Analysis and Statistics
TE D
(http://www.iiam.org/).
Inhibition of DEP, phenanthrene, antimycin A, H2O2, capsaicin and acrolein responses in the isolated
EP
vagus nerve preparation was analysed by a two-tailed paired t-test, comparing responses to agonist in
AC C
the absence and presence of antagonist in the same piece of nerve. Data are presented as mean ± s.e.m., with statistical significance set at P < 0.05. In the single fibre experiments, data was analysed by paired t-test, comparing responses (absolute values) after stimulus to baseline values immediately preceding the response. Data are presented as mean ± s.e.m., with statistical significance set at P<0.05. Inhibition of fibre firing was analysed by paired t-test comparing responses following antagonist to control values prior to antagonist administration, or using an unpaired t-test comparing responses to vehicle control as appropriate. 9
ACCEPTED MANUSCRIPT
DEP-induced activation of airway sensory nerves.
RI PT
RESULTS
Intratracheal instillation of DEP (10µg/ml in PBS, dose-volume 200 µl) in an anaesthetized guinea-pig
SC
model23,24 evoked action potential firing in chemosensitive C-fibers (Figure 1A & B), but not the mechanosensitive Aδ- fibers (Figure. 1C, Table 1). To investigate the mechanism further and to
M AN U
provide translational data, the effect of DEP was examined in an isolated vagal nerve preparation24-26. DEP-evoked concentration-dependent depolarization of the guinea-pig vagus (Figure 1D & E) which was completely abolished in the presence of tetrodotoxin (blocks the flow of sodium ions into nerve cells which is a necessary step in the conduction of nerve impulses in excitable nerve fibers) (TTX –
TE D
3µM; Supplementary Figure 1). DEP also depolarized isolated human vagus tissue in a similar manner to guinea-pig (Figure 1F & E, respectively).
EP
Characterization of DEP.
AC C
DEP are made up of a carbonaceous core surrounded by an organic hydrocarbon component, however the precise size and composition of each particle can vary greatly. Typically, DEP consists of primary nanoparticles (<100nm) that can form larger agglomerates several micrometers in size. The organic components of DEP include polycyclic aromatic hydrocarbons (PAHs) and their derivatives; they also contain traces of numerous transitional metals including iron, vanadium, manganese, copper, zinc and nickel27. Cryo-electron microscopy (cryo-EM) images of the DEP used in these studies (DEP-SRM-2975, commercially-available, generated by a forklift truck) indicated that the individual 10
ACCEPTED MANUSCRIPT primary nanoparticles were roughly spherical, with diameters less than 100 nm; the majority were present as small, irregular agglomerates although larger agglomerates up to several microns were present (Figure 2A). Particle size was quantified by measuring the longest length of the particles and
RI PT
the majority were found to be below 1 µm (mostly <600nm; Fig. 2B and Supplementary figure 2A), which was confirmed by dynamic light scattering (DLS) analysis (Supplementary Figure 2B). Thus, the DEP were in a respirable format that would be expected to deposit throughout the lower respiratory
SC
tract on inhalation. Transmission electron microscopy-Energy-dispersive X-ray spectroscopy (TEMEDX) elemental analysis confirmed low levels of metals (Supplementary Figure 3A-D).
M AN U
Thermogravimetric analysis (TGA) indicated DEP were composed of approximately 15% organic material and 83% inorganic carbon, with the remainder being trace impurities (Figure 2C).
Given that DEP appeared to activate chemosensitive rather than mechanosensitive sensory nerves,
TE D
the organic chemical components of DEP (org-DEP) were separated from the cleaned particulate carbon core (par-DEP) using Soxhlet extraction. In both the guinea-pig and human vagus tissue, orgDEP depolarized the vagus nerve in a similar manner to the whole DEP, whilst par-DEP did not induce
EP
a response (Figure 2D). Having established that the organic extract of DEP was responsible for its
AC C
biological activity and in order to use a characterized and standardized supply we used the commercially-available extract of SRM-2975, namely SRM-1975, in the next experiments (this is referred to in this manuscript as DEP-OE). DEP-OE depolarized the guinea-pig vagus nerve in a concentration dependent manner similar to DEP (Supplementary Figure 4). These results indicate that the organic material embedded on the surface of DEP contains the key components that activate sensory nerves. Polymyxin B (300µg/ml), a cyclic cationic polypeptide antibiotic is widely used to eliminate the effects of endotoxin contamination, both in vitro and in vivo but had no effect on 11
ACCEPTED MANUSCRIPT depolarization induced by DEP-OE (1µg/ml) (Control: 0.1025 ± 0.009mV; Treatment: 0.1023 ±
Role of TRP channels in DEP-OE-induced sensory nerve activation.
RI PT
0.020mV; Recovery: 0.0920 ±0.014mV).
A submaximal concentration of DEP-OE (1µg/ml) was selected for antagonist studies (Supplementary
SC
Figure 4). The specific TRPA1 antagonist Janssen 130 (10µM) significantly inhibited DEP-OE-induced depolarization in the isolated guinea-pig vagus nerve (Figure 3A-B), whilst vehicle (0.1% DMSO), the
M AN U
specific TRPV1 antagonist Xention D0501 (10 nM) and the specific TRPV4 antagonist GSK2193874 (10 µM) had no effect (Figure 3B). Janssen 130 corresponding to the 130 compound of the patent WO2010/141805 A128, also significantly inhibited DEP-OE-induced responses in the human vagus nerve (Figure 3C). These results were confirmed using genetically modified TRP knockout mice (Figure
TE D
3D). Responses in TRPV1-/- and TRPV4-/- mice were not significantly different from WT mice. In vivo, Janssen 130 (300 mg/kg, i.p) significantly inhibited C-fiber firing to both the TRPA1 positive control (acrolein – 10mM) and aerosolized DEP-OE (1 µg/ml) (Figure 3F), while vehicle had no effect (Figure
EP
3E). Janssen 130 (300 mg/kg, i.p) also significantly inhibited the increased tracheal pressure evoked by
AC C
aerosolized DEP-OE (10 µg/ml) (two responses to DEP-OE were evoked before (20.7 ±3.02 and 19.63 ± 1.73 PT ∆ increase cmH2O) and after Janssen130 (5.23 ± 0.79 PT ∆ increase cmH2O, n=3; P<0.05).
Mechanisms of activation of TRPA1 by DEP-OE The ability of DEP to generate oxidative stress has been implicated as a key mechanism driving its adverse health effects29. Oxidative stress and the production of electrophiles have been shown to activate TRPA1 through the covalent modification of cysteine residues30-32. The oxidant H2O2 12
ACCEPTED MANUSCRIPT depolarized the isolated guinea-pig vagus nerve in a concentration dependent manner (Supplementary Figure 5A). Janssen 130 (10 µM), but not vehicle (0.1% DMSO) or TRPV1 antagonism, significantly inhibited H2O2-induced depolarization in the guinea-pig vagus nerve (Supplementary
RI PT
Figure 5B). Vagal nerve from TRPA1-/- mice had significantly reduced depolarization responses to H2O2 compared to tissues from WT mice (Supplementary Figure 5C). In the presence of the antioxidant Nacetylcysteine (NAC, 1 mM), responses to H2O2 (10 mM), acrolein (300 µM) and AITC (300 µM; TRPA1
SC
agonists) were abolished (Figure 4A). DEP-OE-induced depolarization was also abolished by the application of NAC on guinea-pig and human vagus (Figure 4B). When referencing the wide range of
M AN U
electrophilic chemicals present within DEP-OE, phenanthrene (a polycyclic aromatic hydrocarbon; PAH) was identified to be present in relatively high concentrations (SRM-1975 Certificate Analysis Sheet – NIST, USA). PAHs are traditionally thought to exert their toxic effects via induction of the aryl hydrocarbon receptor (AhR), a well conserved transcription factor. The application of two specific AhR
TE D
antagonists CH223191 (10 µM) and 2’, 4’-trimethoxyflavone (TMF; 10 µM) significantly inhibited depolarization responses to both phenanthrene (1 nM) and DEP-OE (Figure 4C & supplementary Figure 6). Depolarization of the vagus nerve by DEP-OE was reduced in AhR-/- mice compared to WT
EP
(Figure 4D). Furthermore, Antimycin A, a mitochondrial electron transport chain inhibitor and
AC C
generator of mitochondrial oxidant stress, depolarized the vagus nerve in a concentration dependent manner (Supplementary Figure 7A) and this response could be inhibited by the mitochondrial superoxide scavenger MitoTEMPO (2µM; Supplementary Figure 7B). MitoTEMPO was capable of reducing the depolarization induced by DEP-OE (1µg/ml) compared to vehicle controls (Figure 4E). These data suggest that electrophilic compounds, such as the PAHs present in DEP, activate TRPA1 through an oxidative stress mechanism which involves AhR and the generation of mitochondrial oxidative stress. 13
ACCEPTED MANUSCRIPT
Translational experiments with generator diesel In the studies presented we used a characterized and standardized supply of commercially available
RI PT
DEP (DEP-SRM-2975, generated by a forklift truck). However, we also repeated key observations with generator DEP which has been aged and diluted to mimic “real-world” occupational and environmental conditions. This generator diesel has been used in controlled human exposure studies
SC
and is associated with a range of respiratory symptoms10,11,22. In these experiments depolarizations of the guinea pig vagus evoked by generator DEP (1µg/ml) were inhibited by the TRPA1 antagonist Jan
M AN U
130 (10 µM) (Figure 5A & C) or the antioxidant NAC (1 mM) (Figure 5B & C) confirming results obtained with DEP-SRM.
DISCUSSION
TE D
Epidemiological studies have found strong associations between exposure to DEP and respiratory symptoms including cough, wheeze and shortness of breath6, 7. In addition, links have been made between combustion-derived PM and asthma symptoms and exacerbations33. DEP exposure has also
EP
been strongly associated with acute worsening of lung function34 and airway hyperreactivity in
AC C
asthmatic subjects35. Although a large number of previous studies have focused on the inflammatory effects of DEP on airway epithelium and immune cells36,37, it is still not known how DEP can evoke respiratory reflexes and the associated symptoms, or by what mechanisms.
Initial studies confirmed our hypothesis that intratracheal instillation of DEP could directly activate airway sensory afferent nerves. However, contrary to our expectations that PM would activate mechanosensitive, rapidly adapting receptors (RARs) or Aδ-fibers, it was the chemosensitive C-fibers 14
ACCEPTED MANUSCRIPT where action potential discharge was noted in response to DEP. The isolated vagus preparation was used to confirm these observations and to investigate this mechanism further because it is an in vitro technique amenable to precise pharmacological study, without the complications often associated
RI PT
with the interpretation of in vivo experiments16,24-26,38. Furthermore, and importantly, the use of the human vagus nerve preparation allowed the generation of translational data and provided an early indicator that data generated in guinea-pig vagus were predictive of effects in man. The potential for
SC
DEP to directly activate airway sensory nerves has important implications, given that millions of individuals living in urban environments are exposed to DEP on a daily basis and that activation of
M AN U
airway sensory nerves can result in a wide range of respiratory symptoms which can be particularly debilitating for those with underlying respiratory conditions compared to healthy people.
Given its complex composition, DEP (SRM-2975) underwent physicochemical characterization so that
TE D
the biological data could be more easily interpreted. Cryo-EM imaging indicated that the majority of DEP were present in small agglomerates and TEM-EDX analysis indicated that a low level of metal impurities were present, in agreement with some previous studies39. The TGA weight loss profile
EP
revealed that the DEP was composed of approximately 15% organic material, 83% inorganic carbon
AC C
material and 2% of trace impurities as measured by weight. These findings are in general agreement with existing published literature40,
41
. Soxhlet extraction of DEP resulted in two separated
components, the cleaned carbon particle core (par-DEP) and the organic extract (org-DEP). Only the org-DEP, and not the par-DEP, activated the vagus nerve commensurate with an activity on the chemosensitive rather than the mechanosensitive airway afferents. Other experiments have also highlighted the importance of the organic components of DEP40, 41 in its bio-reactivity in vitro and in
15
ACCEPTED MANUSCRIPT vivo although we acknowledge that the par-DEP may be responsible for other biological effects of diesel.
RI PT
TRP channels are environmental sensors and initiate the activation of airway sensory nerves in response to exogenous and endogenous stimuli17. Utilizing pharmacological intervention and tissues from genetically modified mice, we demonstrated that DEP-OE-induced activation of airway sensory
SC
nerves and increased tracheal pressure (indicative of airflow obstruction) was through the activation of TRPA1. Although sensory afferents arising from the dorsal root ganglia (DRGs) are not airway
M AN U
innervating and calcium influx measurements are not assessing action potential generation our observations are consistent with data that demonstrated that DEP could activate rodent DRG neurons20. This key result was also demonstrated utilizing human vagus nerve. TRPA1 is expressed exclusively on airway C-fibers, is activated by a number of toxic environmental irritants and has been
TE D
shown to cause cough in both humans and guinea-pigs25. TRPA1 is also thought to be a key channel involved in the late asthmatic response in a rat model of allergic inflammation42 and TRPA1 gene polymorphisms have been associated with childhood asthma43. TRPA1 can be activated by
EP
electrophiles via the covalent modification of cysteine residues on the cytoplasmic N-terminus of the
AC C
channel44, 45and this explains its sensitivity to reactive species that have an innate oxidative potential or the ability to generate intracellular oxidative stress44, 46. In this present study, we confirm that H2O2 was also able to depolarize the vagus nerve in a TRPA1-dependent manner47, 48 and that responses to H2O2 and DEP-OE were inhibited by the general anti-oxidant N-acetyl cysteine (NAC). This is in general agreement with previous studies where the effects of DEP have been inhibited by the application of NAC11, 49. DEP, like other PM, is known to have a redox potential50 and these results suggest that certain organic compounds with oxidative potential within DEP-OE are activating TRPA1. 16
ACCEPTED MANUSCRIPT
Identification of the specific compounds that are responsible for neuronal activation is important, as it may allow for strategies to be developed to produce safer diesel emissions. Although the list of
RI PT
compounds present in DEP-OE is extensive certain classes of compounds appear to be likely candidates for the observed activation of TRPA1. PAHs are present on the surface of DEP and are known to possess toxic and carcinogenic properties. Phenanthrene, one of the most commonly
SC
studied PAHs, is found in higher concentrations in DEP-OE compared to other chemicals. Phenanthrene depolarized the vagus nerve in a similar manner to DEP-OE, and this depolarization was
M AN U
blocked by a TRPA1 antagonist suggesting that this was one of the chemicals responsible for the activation of TRPA1. However, given the number of chemicals within DEP that share similar attributes, such as other PAHs or nitro-PAHs, it is unlikely to be the only activator of this pathway.
TE D
The toxic effects of PAHs are traditionally thought to be mediated by the cytosolic aryl hydrocarbon receptor (AhR), a highly conserved and expressed transcriptional regulator51, 52. Upon ligand binding, AhR is transported to the nucleus whereby it heterodimerises to the aryl hydrocarbon nuclear
EP
translocator (ARNT) and forms a complex so that the transcription of regulatory sequences that
AC C
contain xenobiotic response elements can occur53. Target genes include detoxification response enzymes such as the widely studied CYP1A1 enzyme54. After transcription has occurred, AhR is transported back to the nucleus and degraded. Previous studies in other experimental systems have shown that PAHs present within DEP can activate AhR signaling cascades55-57 and DEP containing greater PAH content induces greater cytotoxic responses in a human bronchial epithelial cell line58. However, typically these transcriptional events occur over time courses that span several hours, at odds with the present study, where we have shown that inhibition of AhR (either in vagal tissue from 17
ACCEPTED MANUSCRIPT AhR knockout mice or using small molecule inhibitors) immediately, and significantly, reduced the depolarization that occurred in response to DEP-OE and phenanthrene. As AhR inhibition had no effect on the TRPA1 agonist acrolein, it is likely that AhR is playing a role upstream of TRPA1.
RI PT
Interestingly, AhR has been identified in the mitochondria where it has been associated with mitochondrial reactive oxygen species (ROS) production and these effects are thought to be independent of either CYP1A1 or CYP1A259. Vagal sensory fibers are densely packed with
SC
mitochondria49. Antimycin A, which evokes ROS from mitochondrial complex III, has been demonstrated to evoke action potential discharge from nociceptive C-fiber terminals innervating the
M AN U
mouse airways in a TRPA1-dependent manner60. In this study, we confirmed that antimycin A evoked vagal sensory nerve activation and that this, and the effect of DEP-OE, were inhibited by the mitochondrial superoxide scavenger MitoTEMPO. These unique findings describe for the first time, a non-transcriptional signaling pathway for AhR and a role for mitochondrial ROS in the activation of
TE D
airway sensory nerves and the initiation of respiratory reflex events evoked by urban air pollution.
In order to assess the physiological relevance of the DEP-SRM used experimentally with regard real
EP
life situations we also repeated key observations with generator DEP which has been aged and diluted
AC C
to mimic “real-world” occupational and environmental conditions. In these experiments depolarization of the guinea pig vagus evoked by generator DEP was inhibited by the TRPA1 antagonist or the antioxidant NAC confirming results obtained with DEP-SRM. This generator diesel has been used in controlled human exposure studies and is associated with a range of respiratory symptoms10,11.
18
ACCEPTED MANUSCRIPT In conclusion, in this study we demonstrate a direct interaction between DEP and airway C-fiber afferents mediated via an oxidative stress pathway and activation of the TRPA1 ion channel expressed on airway afferents. PAHs, major constituents of DEP, are implicated in this process via activation of
RI PT
the AhR and subsequent mitochondrial ROS production which is known to activate TRPA1 on nociceptive C-fibers. These findings provide the first mechanistic insights into how exposure to a significant component of urban particulate air pollution might precipitate respiratory symptoms such
SC
as cough and bronchospasm. A comparison between PAH content of diesel fuels and wider pollutants and TRPA1 mediated activation of airway sensory nerves will lead to further insights into the
M AN U
mechanisms driving the harmful effects of air pollution on the respiratory tract and mitigation strategies for those who are affected and at risk.
COMPETING INTERESTS
TE D
MGB and MAB are directors of an Imperial College spinout contract research company engaged in respiratory pre-clinical work. MGB is a consultant for Ario Pharma, Aboca, Patara, NeRRe,
AC C
EP
MedImmune, Boehringer Ingelheim.
ACKNOWLEDGEMENTS
TRPV1-/- breeding pairs were backcrossed on to the C57BL/6 background and were obtained originally from Jackson Laboratories (Bar Harbour, ME). TRPA1-/- mice were originally developed by Professor David Julius (UCSF, USA) and supplied as backcrossed 10 generations on to C57BL/6 background by Professor Peter Zygmunt from Lund University. Homozygous breeding pairs of mice genetically modified to disrupt the TRPV4 gene (Trpv4-/-; RBRC No. 01939) were obtained from Riken 19
ACCEPTED MANUSCRIPT BioResource Center (Tsukuba, Japan). Vagal tissue was obtained from AhR-/- mice provided as a generous gift by Dr. Rebecca Dearman from the University of Manchester (UK) and Dr Mark Hayes
RI PT
(Imperial College).
REFERENCES
1. Kelly FJ, Fussell JC, Air pollution and airway disease. Clin. Exp. Allergy. 2011; 41: 1059-1071.
SC
2. Shah S, Cocker D, Miller JW, Norbeck JM. Emission rates of particulate matter and elemental and organic carbon from use in diesel engines. Environ Sci Technol 2004; 38: 2544-2550.
Immunol., 2005; 115: 221-228.
M AN U
3. Rield M, Diaz-Sanchez D. Biology of diesel exhaust effects on respiratory function. J Allergy Clin
4. Cames M, Helmers E. Critical evaluation of the European diesel car boom - global comparison, environmental effects and various national strategies. Environmental Sciences Europe, Bridging
TE D
Science and Regulation at the Regional and European Level. 2013; 25:15. 5. Lewis AC, Carslaw DC, Kelly FJ. Vehicle emissions: Diesel pollution long under-reported. Nature. 2015; 526:195.
EP
6. McClellan RO. Health effects of exposure to diesel exhaust particulates. Annu. Rev. Pharmacol.
AC C
Toxicol. 1987; 27: 279-300.
7. Bernstein DI. Diesel exhaust exposure, wheezing and sneezing. Allergy Asthma Immunol. Res, 2012; 4: 178-183.
8. Samoli E, Atkinson RW, Analitis A, Fuller GW, Green DC, Mudway I, et al., Associations of shortterm exposure to traffic-related air pollution with cardiovascular and respiratory hospital admissions in London, UK. Occup Environ Med. 2016; 73:300-7.
20
ACCEPTED MANUSCRIPT 9. Atkinson RW, Analitis A, Samoli E, Fuller GW, Green DC, Mudway IS, et al., Short-term exposure to traffic-related air pollution and daily mortality in London, UK. J Expo Sci Environ Epidemiol. 2016; 26:125-32.
RI PT
10. Rudell B, Ledin MC, Hammarström U, Stjernberg N, Lundbäck B, Sandström T. Effects on symptoms and lung function in humans experimentally exposed to diesel exhaust. Occup Environ Med. 1996; 53:658-62.
SC
11. Carlsten C, MacNutt MJ, Zhang Z, Sava F, Pui MM. Anti-oxidant N-acetylcysteine diminishes diesel exhaust-induced increased airway responsiveness in person with airway hyper-reactivity.
M AN U
Toxicological Sciences 2014; 139: 497-487.
12. Stenfors N, Nordenhäll C, Salvi SS, Mudway I, Söderberg M, Blomberg A, et al., Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J. 2004; 23:82-6.
TE D
13. Nasra J, Belvisi MG. Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis. Pharmacol. Ther. 2009; 124: 354–375. 14. Canning BJ, Mori N, Mazzone SB. Vagal afferent nerves regulating the cough reflex. Respiratory
EP
Physiology & Neurobiology Respir Physiol Neurobiol. 2006;152: 223-42.
AC C
15. Canning BJ, Chang AB, Bolser DC, Smith JA, Mazzone SB, McGarvey L; CHEST Expert Cough Panel; CHEST Expert Cough Panel. Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report. Chest, 2014; 146: 1633-48. 16. Bonvini SJ, Birrell MA, Smith JA, Belvisi MG. Targeting TRP channels for chronic cough: from bench to bedside. Naunyn-Schmiedeberg's Arch Pharmacol 2015; 388: 1–20. 17. Grace MS, Baxter M, Dubuis E, Birrell MA, Belvisi MG. Transient receptor potential (TRP) channels in the airway: role in airway disease. Br J Pharmacol. 2014; 171, 2593-607. 21
ACCEPTED MANUSCRIPT 18. Belvisi MG, Dubuis E, Birrell MA. Transient receptor potential A1 channels: insights into cough and airway inflammatory disease. Chest 2011; 140: 1040-7. 19. Li J, Kanju P, Patterson M, Chew W-L, Cho S-H, Gilmour I, et al., TRPV4-Mediated Calcium Influx into
RI PT
Human Bronchial Epithelia upon Exposure to Diesel Exhaust Particles. Environ Health Perspect. 2011; 119: 784–793.
20. Deering-Rice CE, Romero EG, Shapiro D, Hughen RW, Light AR, Yost GS, et al., Electrophilic
SC
components of diesel exhaust particles (DEP) activate transient receptor potential ankyrin-1 (TRPA1): a probable mechanism of acute pulmonary toxicity for DEP. Chem Res Toxicol, 2011; 24:
M AN U
950-9.
21. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412. 22. Birger N, Gould T, Stewart J, Miller MR, Larson T, Carlsten C. The Air Pollution Exposure Laboratory
TE D
(APEL) for controlled human exposure to diesel exhaust and other inhalants: characterization and comparison to existing facilities. Inhal Toxicol. 2011; 23: 219-25. 23. Adcock JJ, Douglas GJ, Garabette M, Gascoigne M, Beatch G, Walker M, et al., RSD931, a novel anti-
EP
tussive agent acting on airway sensory nerves. Br J. Pharmacol 2003; 138: 407–416.
AC C
24. Bonvini SJ, Birrell MA, Grace MS, Maher SA, Adcock JJ, Wortley MA et al., Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate. J Allergy Clin Immunol. 2016; 138(1):249-261. 25. Birrell MA, Belvisi MG, Grace M, Sadofsky L, Faruqi S, Hele DJ et al., TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med., 2009; 180: 1042-7. 26. Maher SA, Birrell MA, Belvisi MG. Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med. 2009; 180: 923-8 22
ACCEPTED MANUSCRIPT 27. Singh, P, DeMarini DM, Dick CAJ, Tabor TG, Ryan JV, Linak WP et al., Sample characterization of automobile and forklift diesel exhaust particles and comparative pulmonary toxicity in mice. Environ Health Perspect. 2004; 112: 820–825.
RI PT
28. WO2010/141805 A1, PCT/US2010/03738. Heterocyclic amides as modulators of TRPA1, Janssen Pharmaceutic
29. Li N, Wang M, Oberley TD, Sempf JM, Nel AE. Comparison of the pro-oxidative and
and macrophages. J Immunol, 2002; 169: 4531-4541.
SC
proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells
M AN U
30. Taylor-Clark TE. Oxidative stress as activators of sensory nerves for cough. Pul Pharmacol & Ther 2015; 35, 94-99.
31. Hinman A, Chaung HH, Bautista DM, Julius D. TRP channel activation by reversible covalent modification. Proc Natl Acad Sci USA 2006; 103, 19564-19568.
TE D
32. Macpherson LJ, Dublin AE, Evans MJ, Marr F, Schultz PG, Cravatt BF et al., Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007; 445: 541-5. 33. Atkinson RW, Snderson HR, Sunyer J, Ayres J, Baccini M, Vonk JM et al., Acute effects of particulate
EP
air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a
AC C
European Approach. Am J Respir Crit Care Med. 2001; 164, 1860-6. 34. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, Stewart-Evans J, Malliarou E, Jarup L, et al., Respiratory Effects of Exposure to Diesel Traffic in Persons with Asthma. N Engl J Med 2007; 357: 2348-2358.
35. Nordenhall C, Pourazar J, Ledin M-C, Levin J-O, Sandstrom T, Adelroth E. Diesel exhaust enhances airway responsiveness in asthmatic subjects. Eur Respir J 2001; 17: 909-915.
23
ACCEPTED MANUSCRIPT 36. Carlsten C, Blomberg A, Pui M, Sandstrom T, Wong SW, Alexis N et al., Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals: a controlled human exposure study. Thorax 2016; 71: 35-44.
RI PT
37. Hosseini A, Hirota JA, Hackett TL, McNagny KM, Wilson SJ, Carlsten C. Morphometric analysis of inflammation in bronchial biopsies following exposure to inhaled diesel exhaust and allergen challenge in atopic subjects. Part Fibre Toxicol. 2016; 13 : 2.
SC
38. Grace M, Birrell, MA, Dubuis E, Maher SA, Belvisi MG. Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. Thorax 2012; 67: 891–900.
M AN U
39. Ball JC, Straccia, AM, Young WC, Aust AE. The formation of reactive oxygen species catalyzed by neutral, aqueous extracts of NIST ambient particulate matter and diesel engine particles. Journal of the Air & Waste Management Association 2000; 50: 1897–1903.
40. Ma J, Ma J. The dual effect of the particulate and organic components of diesel exhaust particles
TE D
on the alteration of pulmonary immune/inflammatory responses and metabolic enzymes. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 2002; 20: 117-147 41. Totlandsdala AI, Hersethb JI, Bøllinga AK, Kubátovác A, Braund A, Cochranc RE, et al., Differential
AC C
208: 262–268.
EP
effects of the particle core and organic extract of diesel exhaust particles. Toxicology Letters 2012;
42. Raemdonck K, de Alba J, Birrell MA, Grace M, Maher SA, Irvin CG, et al., A role for sensory nerves in the late asthmatic response. Thorax, 2012; 67: 19-25. 43. Gallo V, Dijk FN, Holloway JW, Ring SM, Koppelman GH, Postma DS, et al., TRPA1 gene polymorphisms and childhood asthma. Pediatr Allergy Immunol. 2017; 28:191-198. 44. Bessac BF, Sivula M, von Hehn CA, Escalera J, Cohn L, Jordt SE. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J. Clin. Invest. 2008; 118: 1899–1910. 24
ACCEPTED MANUSCRIPT 45. Cvetkov TL, Huynh KW, Cohen MR, Moiseenkova-Bell VY. Molecular architecture and subunit organization of TRPA1 ion channel revealed by electron microscopy. J Biol Chem 2011; 286: 38168– 38176.
ankyrin 1 in mice. Neurosci Bull 2012; 28: 145–154.
RI PT
46. Liu T, Ji R-R. Oxidative stress induces itch via activation of transient receptor potential subtype
47. Hadley SH, Bahia PK, Taylor-Clark TE. Sensory nerve terminal mitochondrial dysfunction induces
SC
hyperexcitability in airway nociceptors via protein kinase C. Mol Pharmacol 2014; 85: 839-48. 48. Taylor-Clark TE. Oxidative stress as activators of sensory nerves for cough. Pulm Pharmacol Ther.
M AN U
2015; 35: 94-9.
49. Tseng CY, Chang JF, Wang JS, Chang YJ, Gordon MK, Chao MW. Protective Effects of N-Acetyl Cysteine against Diesel Exhaust Particles-Induced Intracellular ROS Generates Pro-Inflammatory
10(7):e0131911.
TE D
Cytokines to Mediate the Vascular Permeability of Capillary-Like Endothelial Tubes. PLoS One 2015;
50. Shinyashiki M, Eiguren-Fernandez A, Schmitz DA, Di Stefano E, Li N, Linak WP et al., Electrophilic and redox properties of diesel exhaust particles. Environ Res. 2009; 109:239-44.
EP
51. Tuyen, le H, Tue NM, Suzuki G, Misaki K, Viet PH, Takahashi S, et al., Aryl hydrocarbon receptor
AC C
mediated activities in road dust from a metropolitan area, Hanoi-Vietnam: contribution of polycyclic aromatic hydrocarbons (PAHs) and human risk assessment. Sci Total Environ 2014; 491492:246-54.
52. Billiard SM, Timme-Laragy AR, Wassenberg DM, Cockman C, Di Giulio RT. The Role of the Aryl Hydrocarbon Receptor Pathway in Mediating Synergistic Developmental Toxicity of Polycyclic Aromatic Hydrocarbons to Zebrafish. Toxicological Sciences 2006; 92: 526–536.
25
ACCEPTED MANUSCRIPT 53. Rowlands JC, Gustafsson JA. Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 1997; 27: 109-34. 54. Whitlock JP Jr. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol. 1999; 39:103-25.
RI PT
55. Soontjens CD, Holmberg K, Westerholm RN, Rafter JJ. Characterization of polycyclic aromatic compounds in diesel exhaust particulate extract responsible for aryl hydrocarbon receptor activity. Atmospheric Environment 1997; 31: 219–225.
SC
56. Misaki K, Suzuki M, Nakamura M, Handa H, Iida M, Kato T, et al., Aryl hydrocarbon receptor and estrogen receptor ligand activity of organic extracts from road dust and diesel exhaust particulates.
M AN U
Arch Environ Contam Toxicol 2008; 55: 199-209.
57. Izawa H, Kohara M, Watanabe G, Taya K, Sagai M. Effects of diesel exhaust particles on the male reproductive system in strains of mice with different aryl hydrocarbon receptor responsiveness. J Reprod Dev 2007; 53: 1191–1197.
TE D
58. Totlandsdal AI, Låg M, Lilleaas E, Cassee F, Schwarze P. Differential proinflammatory responses induced by diesel exhaust particles with contrasting PAH and metal content. Environ. Toxicol. 2015; 30:188-96.
EP
59. Senft PA, Dalton TP, Nebert DW, Genter MB, Puga A, Hutchinson RJ, et al. Mitochondrial reactive
AC C
oxygen production is dependent on the aromatic hydrocarbon receptor. Free Radic Biol Med, 2002; 33: 1268-1278.
60. Nesuashvili L, Hadley SH, Bahia PK, Taylor-Clark TE. Sensory nerve terminal mitochondrial dysfunction activates airway sensory nerves via transient receptor potential (TRP) channels. Mol Pharmacol. 2013; 83: 1007-19.
26
ACCEPTED MANUSCRIPT FIGURE LEGENDS Figure 1. DEP activates airway sensory afferents. (A) Representative trace of action potential firing induced by vehicle (PBS) or DEP (10µg/ml, I.T.) recorded from a guinea pig, airway C-
RI PT
fiber afferent. (B-C) Peak action potential impulses induced by vehicle (PBS) or DEP in airway C-fiber (Figure 1B; n=3) and Aδ-fiber afferents (Figure 1C; n=4). *p <0.05, paired t-test. (D) DEP concentration response in isolated vagus nerve (n=4) *p <0.05, repeated measures one-
SC
way ANOVA with Dunnett post hoc test compared against vehicle. (E) Representative trace of depolarization induced by DEP (1µg/ml) in isolated guinea-pig vagus nerve. (F)
M AN U
Representative trace of depolarization induced by DEP (1µg/ml) in isolated human vagus nerve. Data in histograms is expressed as mean ± SEM.
Figure 2. Physicochemical characterization of DEP. (A) Cryo-electron microscopy (cryo-EM)
TE D
image of DEP (1µg/ml, Krebs). (B) Size distribution of DEP (1µg/ml, Krebs) as measured by longest dimension, including agglomerates, derived from cryo-EM images (particle count = 394). Note that agglomerates larger than 600 nm were also present but in low numbers (See
EP
supplementary Figure 2) (C) Thermogravimetric analysis (TGA) weight loss profile of DEP
AC C
when heated to 850 °C in air, showing (a) organic component fraction and (b) inorganic carbon fraction (D) Example trace and summary data of the effects of org-DEP (1µg/ml), parDEP (1µg/ml) and DEP (1µg/ml) in isolated guinea-pig (n=4) and human (n=2) vagus tissue. Data expressed as mean ± SEM for guinea-pig. Depolarisation of human vagus was assessed in response to org-DEP (0.03mV and 0.05mV) to par-DEP (0mV, 0mV) and DEP (0.06 mV, 0.04mV).
27
ACCEPTED MANUSCRIPT Figure 3. Effect of TRP antagonists on DEP-OE-induced vagal sensory nerve activation. (A) Trace showing the effect of the transient receptor potential ankyrin-1 (TRPA1) antagonist (Janssen 130, 10 µM) on DEP-OE (1µg/ml)-induced depolarization of the guinea-pig vagus
RI PT
nerve (B) Percentage inhibition of DEP-OE by vehicle (0.1% DMSO and antagonists- TRPA1Janssen 130 (10 µM), TRPV1 – Xention D0501 (100 nM), TRPV4 – GSK 2193874 (10 µM)) in guinea-pig vagal tissue (n=4-7) *p <0.05, paired t-test comparing antagonist responses to
SC
control in the same tissue. (C) Percentage inhibition of DEP-OE-induced responses by Jansen 130 (10 µM) in human vagus tissue (n=3) *p <0.05, paired t -test comparing antagonist
M AN U
responses to control in the same tissue. (D) DEP-OE depolarization in the isolated vagus nerve of TRP KO mice (n=4-6). *p <0.05, unpaired t-test. (E) Effect of vehicle (0.5% methyl cellulose and 0.2% Tween in saline) or (F) Janssen 130 (300 mg/kg i.p) on DEP-OE (1µg/ml, aerosol for 60s), acrolein (10mM, aerosol for 60s) and capsaicin (100 µM, aerosol for 15s)
TE D
(n=3) -induced firing of guinea-pig, vagal C-fibers. White bars indicate peak impulses recorded immediately prior to application of agonists *p <0.05, paired t-test. Data expressed
EP
as mean ± SEM.
AC C
Figure. 4. Mechanism involved in the activation of TRPA1 by DEP-OE (1µg/ml). (A) Inhibition of H2O2 (10 mM) and transient receptor potential ankyrin-1 (TRPA1) agonist (300 µM) induced depolarization of guinea-pig isolated vagus nerve by N-acetylcysteine (NAC, 1 mM) (N=4-7) *p <0.05, paired t-test comparing antagonist responses to control responses in the same tissue. (B) Percentage inhibition of DEP-OE-induced depolarization by NAC (black bars, 1 mM) in guinea-pig (n=4). Depolarization to DEP-OE of human vagus was assessed in the presence of vehicle (0.06mV, 0.04mV before compared to 0.05mV, 0.03mV after) or NAC 28
ACCEPTED MANUSCRIPT (0.04mV, 0.08mV before compared to 0mV, 0mV after) (n=2). (C) Percentage inhibition of phenanthrene (Phen; 1nM) and DEP-OE-induced depolarization by aryl hydrocarbon receptor (AhR) antagonist CH223191 (10 µM; N=4-6) in guinea-pig isolated vagal tissue. *p <0.05,
RI PT
paired t-test comparing antagonist responses to control responses in the same tissue. (D) Depolarization induced by DEP-OE in isolated vagal tissue from AhR-/- mice (N=3). (E) Inhibition of DEP-OE-induced depolarization by MitoTEMPO (2µM) in guinea-pig isolated
SC
vagal tissue (N=5) *p <0.05, unpaired t-test. Data expressed as mean ± SEM.
M AN U
Figure 5. Effect of Jan 130 and NAC on generator DEP-induced depolarization of guinea-pig vagus nerve. Trace showing the effect of the transient receptor potential ankyrin-1 (TRPA1) antagonist Jan 130 (10 µM) (A) or the antioxidant NAC (1 mM) (B) on generator DEP (1µg/ml)-induced depolarization of the guinea-pig vagus nerve. (C) Summary graph of effect
TE D
of vehicle (0.1% DMSO), Jan 130 (10 µM) and NAC (1mM) on generator DEP (1µg/ml)induced depolarization. (n=3-5). *p <0.05, paired t-test comparing antagonist responses to
EP
control in the same tissue. Data expressed as mean ± SEM.
AC C
Graphical Abstract Legend: Schematic diagram illustrating how diesel exhaust particles directly stimulate airway afferent nerves. Direct interaction between DEP and airway C-fiber afferents mediated via an oxidative stress pathway and activation of the transient receptor potential ankyrin-1 (TRPA1) ion channel expressed on airway afferents. Polycyclic aromatic hydrocarbons, major constituents of DEP, were implicated in this process via activation of the aryl hydrocarbon receptor (AhR) and subsequent mitochondrial ROS production, which is
29
ACCEPTED MANUSCRIPT known to activate TRPA1 on nociceptive C-fibers which are known to initiate respiratory
AC C
EP
TE D
M AN U
SC
RI PT
symptoms.
30
ACCEPTED MANUSCRIPT TABLE 1
Aδ-Fibre
(CV =< 1m/s) (n=3)
(CV > 1m/s) (n=4)
7.33 ± 0.88*
1.6 ± 0.51
Acrolein (10mM, aerosol)
Capsaicin
8.33 ± 0.33*
1.6 ± 0.68
(Capsaicin sensitive)(Capsaicin insensitive)
11.3 ± 4.05* 1.27 ± 0.37*
TE D
(100µM, aerosol)
8.67 ± 1.20*
M AN U
(10µg/ml, I.T)
SC
DEP
C-Fibre
RI PT
Effect of DEP on airway-specific, afferent nerve fibers in vivo in the guinea-pig.
Table 1 shows peak action potential impulses (imp s-1) induced by DEP (10µg/ml, I.T.), acrolein (10mM in saline, aerosolized for 60s) or capsaicin (100µM in saline, aerosolized for 15s) recorded from airway
EP
C-fiber afferent or Aδ-fiber afferents. Data was analysed by paired t-test, comparing responses (absolute values) after stimulus to baseline values immediately preceding the response. Data are
AC C
presented as mean ± s.e.m., with statistical significance set at P<0.05.
31
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
ONLINE SUPPLEMENT
2
Mechanistic Link between Diesel Exhaust Particles and Respiratory Reflexes
3
Ryan K Robinson BSc1, 2, Mark A Birrell PhD1, 2, John J Adcock PhD1, Michael A Wortley PhD1,
4
Eric D Dubuis PhD1, Shu Chen3, Catriona M McGilvery2, Sheng Hu PhD4, Milo SP Shaffer PhD3,4,
5
Sara J Bonvini PhD1, Sarah A Maher PhD1, Ian S Mudway PhD5, 6, Alexandra E Porter PhD3,6,
6
Chris Carlsten MD7, Teresa D Tetley PhD6,8*, Maria G Belvisi PhD 1,2*.
SC
RI PT
1
7
M AN U
8 9 10 11
15 16 17 18 19
EP
14
AC C
13
TE D
12
20 21 22 23 1
ACCEPTED MANUSCRIPT 24
DETAILED METHODOLOGY
25
Male Dunkin-Hartley guinea-pigs (Harlan, Bicester, United Kingdom) were used, weighing 300–500 g
27
for in vitro experiments and 400-750g for in vivo single fiber experiments. Male C57BL/6 mice (Harlan,
28
United Kingdom) weighing 18-20 g were used as a background to produce wild type (WT) mice.
29
TRPV1-/- breeding pairs were backcrossed on to the C57BL/6 background and were obtained originally
30
from Jackson Laboratories (Bar Harbour, ME). TRPA1-/- mice were originally developed by Professor
31
David Julius (UCSF, USA) and supplied as backcrossed 10 generations on to C57BL/6 background by
32
Professor Peter Zygmunt from Lund University. Homozygous breeding pairs of mice genetically
33
modified to disrupt the TRPV4 gene were obtained from Riken BioResource Center (Tsukuba,
34
Japan)1,2. Vagal tissue was obtained from AhR-/- mice provided as a generous gift by Dr. Rebecca
35
Dearman from the University of Manchester (UK) and Dr Mark Hayes (Imperial College). Genetic
36
knockouts were confirmed by genotyping. All animals were housed in a climate controlled room (21
37
°C) with food and water freely available for at least 1 week before commencing experiments. All
38
experiments were performed in accordance with the U.K. Home Office guidelines for animal welfare
39
based on the Animals (Scientific Procedures) Act of 1986 and the ARRIVE guidelines3.
SC
M AN U
TE D
EP
AC C
40
RI PT
26
41
Human Tissue and Ethics
42
Human lung and trachea surplus to transplant requirements (N=3, 56-73 years old, 1 male/2 female, 1
43
smoker/2 non-smokers), with the vagus nerve still attached, were used to obtain translational data to
44
compliment data generated in guinea pig tissue. Briefly, the vagus tissue was dissected from around
45
the trachea and airways and dissected under microscope to produce sections suitable for in vitro
46
experiments (see below). Tissue was provided by the International Institute for the Advancement of 2
ACCEPTED MANUSCRIPT 47
Medicine (IIAM, Edison, New Jersey, USA). In all cases the tissue was approved for use in scientific
48
research and ethical approval was obtained from the Royal Brompton & Harefield Trust.
49
Compounds and Materials
51
Diesel exhaust particles from a forklift truck (DEP - SRM-2975) and its commercial organic extract
52
(DEP-OE - SRM-1975) were purchased from the National Institute of Standards and Technology (NIST,
53
Gaithersburg, USA). Capsaicin (TRPV1 agonist), acrolein (TRPA1 agonist), allyl isothiocyanate (AITC –
54
TRPA1 agonist), citric acid (CA), methyl cellulose, phosphate buffered saline (PBS), hydrogen peroxide
55
(30% v/v; H202), n-acetyl cysteine (NAC), CH223191, antimycin A, (2-(2,2,6,6-Tetramethylpiperidin-1-
56
oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chloride (Mito-TEMPO), Polymyxin B sulfate salt,
57
dichloromethane (DCM) and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich
58
Company Ltd (Dorset, UK). 6,2',4'-Trimethoxyflavone (TMF) was purchased from Tocris Bioscience
59
(Bristol, UK). Janssen 130 (Jan 130 – TRPA1 antagonist) corresponding to the compound 130 of the
60
patent WO2010/141805 A1 and GSK2193874 (GSK219 - TRPV4 antagonist) were synthesised by the
61
Medicinal Chemistry Department in Almirall (Almirall S.A., Barcelona, Spain). Phenanthrene was a
62
generous gift from Dr. Ian Mudway (Kings College London, UK). Xention D0501 (TRV1 antagonist) was
63
provided by Ario Pharma Ltd (Cambridge, UK). Drugs were made up in stock solutions using DMSO,
64
with the final concentration of DMSO kept at 0.1% for experiments.
66
SC
M AN U
TE D
EP
AC C
65
RI PT
50
67
Particle Suspensions
68
Particle suspension solutions were freshly prepared daily. Suspensions of DEP or par-DEP were
69
prepared in a modified Krebs-Henseliet solution (Krebs, in mM: NaCl 118; KCl 5.9; MgSO4 1.2; 3
ACCEPTED MANUSCRIPT 70
NaH2PO4 1.2; CaCl2 2.5; glucose 6.6; NaHCO3 25.5,) by sonication in a water bath for 10 minutes,
71
before dilution to working concentrations. For in vivo experiments, suspensions were prepared in PBS
72
in a similar manner.
74
RI PT
73
Physiochemical characterization of DEP
75
Electron Microscopy
77
The cryo preparation was done using a Leica GP automatic plunge freezer (Leica Microsystems, Milton
78
Keynes). Nanoparticles, dispersed in (1µg/ml in Krebs), were dropped onto a grid and frozen by
79
rapidly plunging into liquid ethane. These were transferred in their frozen state into a cryo-rod
80
(Gatan 914) and then into the electron microscope. The electron microscopy was carried out on a
81
Jeol 2100F equipped with a Schottky Field Emission Gun (FEG) and operated at 200kV.
M AN U
SC
76
TE D
82
For chemical analysis, DEP samples were dispersed by sonication in ethanol and then pipetted onto a
84
grid at room temperature. TEM and Energy Dispersive X-ray Spectroscopy (EDX) analysis was
85
performed on an FEI Titan 80–300 (S)TEM operated at 300 kV, fitted with a Cs (image) corrector and
86
SiLi EDX spectrometer (EDAX, Leicester UK). EDX was carried out by condensing the electron beam
87
onto the region of interest and acquiring spectra for 180 seconds.
AC C
88
EP
83
89
Thermogravametric Analysis
90
The organic/inorganic ratio composition of SRM 2975 was assessed using thermogravemetric analysis
91
(TGA) using a Perkin Elmer Pyris 1 machine (PerkinElmer Inc., Beaconsfield, UK), by heating 1.8 ± 0.2
92
mg of DEP to 100 °C, under air flow (flow rate 10 mL/min), and holding isothermally for 30 minutes to 4
ACCEPTED MANUSCRIPT 93
remove residual water and/or solvent; the temperature was then increased from 110 °C to 850 °C at a
94
constant ramping rate of 10 °C/min under air flow (10 mL/min).
95
Dynamic Light Scattering
97
Dynamic light scattering (DLS) measurements were carried out using a ZetaSizer Nano ZS (Malvern,
98
UK). DEP samples were prepared in Krebs solution at 0.1µg/ml and 1µg/ml sonicated briefly in a
99
sonicating water bath immediately before being placed into disposable micro cuvettes. Samples were
100
warmed to 37°C and left to equilibrate for 60 seconds prior to DLS measurements, which were carried
101
out at a 173° backscatter angle and in triplicate for each sample. Measurement run durations were
102
automatically calculated on a per sample basis.
M AN U
SC
RI PT
96
103
Component separation DEP
105
1 g of DEP was loaded into an extraction thimble and extracted overnight with dichloromethane
106
(DCM) using Soxhlet extraction equipment at 40°C. The extract solvent was then evaporated by rotary
107
evaporator, and reconstituted in DMSO up to a volume of 10ml. This resulted in an ‘equivalent
108
concentration’ of organic extract of ‘0.1g/ml’, that represented the organic material present in 1g of
109
DEP now being present in 10ml of DMSO. The resulting DEP organic extract (org-DEP) was centrifuged
110
at 10,000g for 20 minutes to remove remaining particulates and supernatant was carefully removed.
111
DEP-OE was then diluted in DMSO and stored at -80°C until needed. The remaining particles left
112
behind in the paper filter was heated gently overnight to completely evaporate any remaining DCM,
113
and were then kept as cleaned particles (par-DEP).
AC C
EP
TE D
104
114 115 5
ACCEPTED MANUSCRIPT In vivo recording of action potential firing in single-fiber afferents.
117
Guinea-pigs were anaesthetized with urethane (1.5 g/kg) intraperitoneally. If required, anaesthesia
118
was supplemented with additional urethane. The trachea was cannulated with a short length of
119
Portex tubing and blood gases and pH were maintained at physiological levels by artificial ventilation
120
(Ugo Basile small animal ventilator), with a tidal volume of 10 ml kg-1 and 50-60 breaths min-1 of
121
laboratory air. The right jugular vein and carotid artery (passed to the ascending aorta/aortic arch)
122
were cannulated for respectively injecting drugs and measuring systemic arterial blood pressure.
123
Systemic arterial blood pressure and heart rate were continuously recorded using a transducer (Gould
124
P23XL). Tracheal pressure was measured with an air pressure transducer (SenSym 647) connected to
125
a side arm of the tracheal cannula. Body temperature was continuously monitored with a rectal
126
thermometer and maintained at 37ºC with a heated blanket and control unit (Harvard Apparatus).
127
Animals were paralysed with vecuronium bromide, initially administered at a dose of 0.10 mg/kg, i.v.,
128
followed every 20 min with 0.05 mg/kg, i.v. to maintain paralysis. The depth of anaesthesia was
129
frequently assessed by monitoring the response of heart rate and blood pressure to noxious stimuli.
130
Both cervical vagus nerves were located, via a cervical incision, and dissected free from the carotid
131
artery, sympathetic and aortic nerves; both vagus nerves were cut at the central end. The left vagus
132
nerve was used for sensory nerve fiber recording and was cleared of its surrounding fascia. The skin
133
and muscle in the neck at either side of the incision were lifted and tied to a metal ring to form a well,
134
which was filled with light mineral oil. Bipolar Teflon-coated platinum electrodes (exposed at the tips)
135
were used for recording purposes, using fascia positioned on one electrode for a reference. The vagus
136
nerve was placed on a small black perspex plate to facilitate subsequent dissection. Thin filaments of
137
nerve were teased from the vagus nerve, under a binocular microscope, and placed on the second
138
electrode until a single active unit, or one of not more than two or three units, was obtained. Action
AC C
EP
TE D
M AN U
SC
RI PT
116
6
ACCEPTED MANUSCRIPT potentials were recorded in a conventional manner using electrodes connected to a pre-amp
140
headstage (Digitimer NL100K). The signal was amplified (x1000-5000, Digitimer NL104), filtered (in the
141
range of LF30Hz – HF8.5kHz, Digitimer NL125) and passed through a Humbug noise reducer
142
(AutoMate Scientific) before input sampling and recording. All signals were sampled (50 kHz) and
143
recorded using the Spike 2 software data acquisition system via a CED Micro1401 interface. The
144
software allowed pulse train counting over selected time periods. In addition, monitoring of the input
145
signal to the Spike software was also carried out on a digital storage oscilloscope (Tektronix DPO
146
2012). The input signal was also fed through an audio amplifier to a loud speaker.
SC
RI PT
139
M AN U
147
Aerosols were generated by an Aerogen nebulizer (Buxco Nebulizer Control – 5) connected to the
149
ventilator and arranged so that the inspired air passed through the medication chamber before
150
entering the lungs of anaesthetized animals via the tracheal cannula.
151
TE D
148
Single vagal nerve fibers were identified as originating from the major groups of airway sensory nerve
153
endings, i.e., slowly adapting stretch receptors (SARs), rapidly adapting stretch receptors, (RARs,
154
irritant receptors, Aδ-fibers – further subdivided into those which were more acid and/or less
155
capsaicin sensitive and with CVs slower than conventional RARs), and pulmonary/bronchial C-fiber
156
receptors using several criteria4. These include pattern of spontaneous discharge, response to
157
hyperinflation and deflation, adaptation indices (AIs), response to capsaicin/citric acid administration
158
and conduction velocities. As a rule, a receptor that had no obvious pattern to the spontaneous
159
activity (often very sparse), did not respond to hyperinflation/hyperdeflation but responded to
160
capsaicin aerosol was pursued as a C-fiber. Alternatively, and, in the first instance, a receptor that had
AC C
EP
152
7
ACCEPTED MANUSCRIPT 161
a spontaneous discharge with a definite rhythmical respiratory pattern and adapted rapidly/variably
162
to hyperinflation/deflation was pursed as an Aδ-fiber.
163
Following identification of a suitable single nerve fiber, control responses were obtained to capsaicin
165
(100µM in saline, aerosolized for 15s), acrolein (10mM in saline, aerosolized for 60 s) and citric acid
166
(300mM, aerosolized for 60s). The nerve under investigation were then challenged with either vehicle
167
(PBS, 200µL) or DEP (10 µg/ml in PBS, 200µL, intratracheal dose) and subsequent action potentials
168
recorded. For antagonist studies, control responses were obtained to capsaicin (100µM in saline,
169
aerosolized for 15s), acrolein (10mM in saline, aerosolized for 60s) and DEP-OE (1 µg/ml in saline,
170
aerosolized for 60s) prior to the introduction of Janssen 130 (30mg/kg, 1% methyl cellulose in saline)
171
into the animal via intravenous route 60 minutes before challenging again with capsaicin, acrolein and
172
DEP-OE.
SC
M AN U
TE D
173
RI PT
164
At the end of the experiment, the conduction velocity of the single nerve fiber was measured to
175
determine whether it was a slow conducting non-myelinated C-fiber or a fast conducting myelinated
176
Aδ-fiber. This was achieved by stimulating the vagus nerve close to the thorax using a supra threshold
177
voltage (Grass stimulator, 0.5 ms, 1Hz). The corresponding action potential was recorded in the single
178
nerve fiber under observation, and the time between the initial stimuli and the resulting action
179
potential was calculated using the Spike 2 software and used with the measured distance between
180
the two electrodes to calculate the conduction velocity. All animals were culled at the end of
181
experiments with an overdose of pentobarbitone.
AC C
EP
174
182 183 8
ACCEPTED MANUSCRIPT In vitro measurement of isolated vagus nerve depolarization
185
Guinea-pigs and mice were sacrificed by injection of sodium pentobarbitone (200 mg/kg i.p.) and
186
human vagus obtained from IIAM. The vagus nerves were dissected and experiments conducted in a
187
fully characterised isolated vagus preparation as described in previous publications5,6. The two vagus
188
nerve trunks were then placed in Krebs bubbled with 95% O2/ 5% CO2 to stay oxygenated. The vagus
189
tissue was then cleaned of connective tissue before being cut into 15-20mm segments. These
190
segments were then mounted into a ‘grease-gap’ dual recording chamber system, whereby the nerve
191
was threaded through a narrow cylindrical gap between a test chamber and a reference chamber. The
192
ends of the nerve exposed in each chamber were then electrically and chemically isolated by the
193
application of petroleum jelly into the cylindrical gap through a side arm. The end of the nerve
194
exposed in the test chamber was then constantly perfused at a rate of 2 ml/min with oxygenated
195
Krebs heated to 37°C using a custom designed water jacket housing. Borosilicate glass electrodes
196
mounted onto an Ag/AgCl pellet (World Precision Instruments, USA) were filled with Krebs and placed
197
into contact with the nerve in both the test chamber and the reference chamber. Changes in the
198
surface charges between the test and reference chamber were then recorded using an extracellular
199
potential differential amplifier (DAM 50 Bioamplifier, World Precision Instruments, USA). Nerve
200
depolarizations were filtered at 0.3 kHz, amplified x50, and recorded onto a chart recorder
201
(Lectromed Multi-Trace 2). During experiments, the perfusate through the test chamber of the vagus
202
was maintained at 37°C with a rate of 2 ml/min and a change of drug containing solution was made
203
through a manifold. Subsequent vagal depolarization were recorded in response to various stimuli
204
applied for 2 minutes. For general antagonist studies, two repeatable baseline responses to agonists
205
were first obtained before pretreatment with an antagonist for 10 minutes prior to the two minute
206
application of the agonist in the presence of the antagonist. After a ten minute wash out, a recovery
AC C
EP
TE D
M AN U
SC
RI PT
184
9
ACCEPTED MANUSCRIPT response to an agonist was then obtained to confirm nerve viability at the end of the experiment. If a
208
recovery response could not be obtained, the data was disregarded. For mitoTEMPO antagonist
209
studies utilising antimycin A, an irreversible binding electron transport chain inhibitor, and other
210
agonists, nerve viability was confirmed at the beginning of the experiment using acrolein (300µM),
211
before a single application of agonists with or without antagonist present. Responses were compared
212
across different tissues from the same animal.
SC
213
RI PT
207
REFERENCES
215
1. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol
216
Chem 2003; 278: 22664-8 (2003).
217
M AN U
214
2. Mizuno A, Matsumoton N, Imai M, Suzuki M. Impaired osmotic sensation in mice lacking TRPV4.
219
Am J Physiol Cell Physiol 2003; 285: C96-101.
TE D
218
220
3. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting:
222
the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
AC C
223
EP
221
224
4. Adcock JJ, Douglas GJ, Garabette M, Gascoigne M, Beatch G, Walker M, et al., RSD931, a novel anti-
225
tussive agent acting on airway sensory nerves. Br J. Pharmacol 2003; 138: 407–416.
226 227
5. Birrell MA, Belvisi MG, Grace M, Sadofsky L, Faruqi S, Hele DJ, Maher SA, Freund-Michel V, Morice
228
AH. TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care
229
Med.,2009; 180, 1042-7. 10
ACCEPTED MANUSCRIPT 230 231
6. Maher SA, Birrell MA, Belvisi MG. Prostaglandin E2 mediates cough via the EP3 receptor:
232
implications for future disease therapy. Am J Respir Crit Care Med. 2009; 180: 923-8.
RI PT
233
FIGURE LEGENDS
235
Supplementary Figure 1. Effect of TTX on DEP-induced depolarization of guinea-pig vagus nerve. A)
236
Representative trace showing the effect of TTX (3µM) on DEP (1µg/ml) -induced depolarization of
237
guinea-pig vagus nerve. Two control responses were obtained to DEP (1µg/ml), then DEP in the
238
presence of TTX and finally recovery of the response to DEP following washout. B) Summary bar graph
239
showing initial depolarization to DEP (left column), followed by response obtained in the presence of
240
TTX (3 µM; all values 0mV) and a recovery response following wash out (right column) (n=4). Data
241
expressed as mean ± SEM. *p <0.05 as calculated by a paired t-test.
M AN U
TE D
242
SC
234
Supplementary Figure 2. Size characterisation of DEP. (A) Size distribution of DEP (1µg/ml, Krebs) as
244
measured by longest dimension, including agglomerates, as analysed by images produced by cryo-EM.
245
Particles were measured by longest length. (n=394). (B) Dynamic light scattering (DLS) hydrodynamic
246
diameter measurements of DEP in Krebs solution (n=3). Data expressed as mean ± SEM.
AC C
247
EP
243
248
Supplementary Figure 3. Metal species characterisation of DEP. (A) Transmission electron
249
microscopy–energy dispersive X-ray (TEM-EDX) spectrum showing the element analysis profile of a
250
blank carbon film area as a control, with (B) the analyzed blank area of interest depicted. (C) TEM-EDX
251
spectrum showing the profile of detected elements in DEP sample, with (D) the analyzed sample of
11
ACCEPTED MANUSCRIPT 252
interest depicted. The trace of copper X-ray signals and part of the carbon signals are attributed to the
253
holey carbon film coated copper TEM grid and sample holder.
254
Supplementary Figure 4. Effect of DEP-OE on isolated guinea-pig vagus. Concentration dependent
256
depolarization induced by DEP-OE in guinea pig isolated vagus nerve. Arrow indicates concentration
257
selected for subsequent antagonist studies. (n=4-5).
SC
258
RI PT
255
Supplementary Figure 5. Depolarization induced by H2O2 on isolated vagus nerve and effect of
260
pharmacological interventions. A) Concentration response showing depolarization induced by H2O2 in
261
guinea-pig isolated vagus nerve. Arrow indicates concentration selected for subsequent antagonist
262
studies. (n=5-6). B) Effect of vehicle (0.1% DMSO), Janssen 130 (10 µM, all values 0mV) and Xention
263
D0501 (100 nM) on H2O2-induced depolarization. (n=3-5). *p <0.05, paired t test comparing
264
antagonist responses to control responses in the same tissue. C) Effect of H2O2 on depolarization in
265
vagal tissue from WT (white) and TRPA1-/- mice (black) (n=2-3). Data expressed as mean ± SEM.
TE D
266
M AN U
259
Supplementary Figure 6. Effect of TMF on phenanthrene and DEP-OE-induced depolarisation of
268
vagus nerve. Effect of TMF (10µM) on phenanthrene (1nM, n=4) and DEP-OE-induced depolarisation.
269
(n=6). *p <0.05, paired t test comparing antagonist responses to control responses in the same tissue.
270
Data expressed as mean ± SEM.
AC C
271
EP
267
272
Supplementary Figure 7. Effect of MitoTEMPO on antimycin A-induced depolarisation of vagus
273
nerve. A) Concentration response showing depolarization induced by antimycin A in guinea pig
274
isolated vagus nerve. Arrow indicates concentration selected for subsequent antagonist studies. (n=512
ACCEPTED MANUSCRIPT 6). B) – Effect of vehicle (0.1% DMSO) and MitoTEMPO (2µM; all values 0mV) on antimycin A (20µM)-
276
induced depolarization. (n=4). Data expressed as mean ± SEM. *p <0.05, unpaired two tailed t-test.
AC C
EP
TE D
M AN U
SC
RI PT
275
13
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT